BUZZ-LIXTE to buy battery firm NOMAD, shifts away from cancer drugs; shares rise

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc.

LIXT

0.00

** Shares of LIXTE Biotechnology Holdings LIXT.O rise 5.8% to $7.67 premarket

** LIXT says it will acquire NOMAD Transportable Power Systems, which makes portable battery units supplying electricity where grid access is limited

** Says NOMAD's systems can deliver up to 1 megawatt of power and be deployed quickly, avoiding delays tied to permanent installations

** Financial terms of the deal not disclosed

** LIXT to rename itself NOMAD Power Solutions after the deal closes, shifting away from cancer drug development

** NOMAD saw 175% revenue growth in 2025 and expects another 135% rise in 2026; NOMAD CEO says deal will aid manufacturing expansion

** The combined company will focus on mobile, utility-scale battery storage systems

** As of last close, LIXT stock up ~84% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.